Ultrasound after DBT obviates diagnostic 2D mammo

Performing a diagnostic mammogram to assess suspicious masses found on digital...Read more on AuntMinnie.comRelated Reading: Philips launches breast ultrasound package Should the BI-RADS 3 ultrasound category be revised? CAD software speeds up ABUS interpretations How should AI be used in breast ultrasound? ABUS reads are short enough for busy clinical practices
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Conclusions: Our model is more reliable and stable to assist doctors predict the SLN metastasis in breast cancer patients before operation. Introduction The incidence of breast cancer is the first in female malignant tumors, in which the highest incidence of breast cancer has been reported in Europe and the United States, however, in recent years, the incidence of breast cancer in China has annually increased (1, 2). Based on surgery as an important step in the treatment of breast cancer, in recent years, different individuals have never stopped exploration of a novel and optimum approach. Besides, NSABP-04, ASCOG-...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Conclusion: The texture analysis for breast DCE-MRI proposed in this study demonstrated potential utility in HER2 2+ status discrimination. Background Human epidermal growth factor receptor 2 (HER2) is an orphan tyrosine kinase receptor. It is reported that HER2 is overexpressed in 15–20% of breast cancers. Overexpression of HER2 in breast cancer correlates with shortened disease-free survival. Compared with HER2-negative patients, patients with HER2-positive breast cancers have a poor prognosis, a high probability of lymph node metastasis and a high risk of recurrence (1–3). However, previous studies h...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
ConclusionConflicting evidences and lacking data about the benefits in terms of overall survival, disease-free survival and the long-term outcomes related to prophylactic bilateral mastectomy for CDH1 mutation carriers restrict the instruction for this type of procedure to selected cases, which should always be managed by a multidisciplinary team.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
Publication date: Available online 5 April 2019Source: Diagnostic and Interventional ImagingAuthor(s): A. VourtsisAbstractThree-dimensional automated breast ultrasound system (3D ABUS) is an innovation in breast ultrasound that has been developed to uncouple detection from image acquisition and to address the limitations of handheld ultrasound (HHUS). 3D ABUS provides a large field of view using high frequency transducers, producing high-resolution images and covering a large portion of the breast with one sweep. As more data become available on breast density and the impact of supplemental screening, 3D ABUS has gained wi...
Source: Diagnostic and Interventional Imaging - Category: Radiology Source Type: research
Using artificial intelligence (AI) software with digital breast tomosynthesis...Read more on AuntMinnie.comRelated Reading: AI characterizes breast masses on ultrasound AI may help women with ductal hyperplasia avoid surgery AI can reduce mammography screening's workload Mammo AI software yields workflow, economic benefits AI-based CAD software improves breast cancer detection
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
For many years, health plans have been searching for ways to incentivize their members to search for lower priced services such as imaging and surgical procedures like total hip replacement. I believe that the best incentive for this searching and cost-saving behavior is some sort of benefit like cash. A recent article covered this topic (see:How employers save money by paying employees to shop for healthcare) and below is an excerpt from it: According to a new RAND Corp. study published in Health Affairs, paying employees between $25 and $500 for using a transparency tool, and encouraging them to select a lower-...
Source: Lab Soft News - Category: Laboratory Medicine Authors: Tags: Healthcare Business Healthcare Delivery Hospital Financial Medical Consumerism Medical Research Public Health Quality of Care Radiology Source Type: blogs
Conclusion: 18F-FDG PET/CT revealed previously unsuspected distant metastases in 16% of male patients with pre-PET/CT stage IIB breast cancer and 33% of those with stage III breast cancer. These rates are comparable to previously published upstaging rates in female patients. 18F-FDG PET/CT demonstrates value for systemic staging of male patients with breast cancer and should be considered for use in newly diagnosed patients, particularly those with stage IIB and III disease.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Clinical Source Type: research
Abstract Idiopathic granulomatous mastitis (IGM) is a rare inflammatory breast disease mimicking carcinoma and puerperal or non-puerperal mastitis. The primary purpose of this prospectively performed case control study was to compare clinical and imaging signs of IGM with the reference group of nonspecific, non- puerperal mastitis (NM) to identify the most typical clinical and imaging signs essential for a correct differential diagnosis. The secondary purpose was to present a new approach to non-invasive treatment. Thirty-nine women with histologically proven IGM and twenty-six patients with nonspecific mastitis u...
Source: Neoplasma - Category: Cancer & Oncology Authors: Tags: Neoplasma Source Type: research
ConclusionPABC is an aggressive form of breast cancer associated with advanced stage at diagnosis. Despite the existing difficulties in diagnosis, imaging examinations are indispensable. Early diagnosis and multidisciplinary therapy, including anti ‐HER2 targeted therapy, may be important to improve prognosis.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Tags: ORIGINAL ARTICLE Source Type: research
Volpara Solutions said yesterday that it expanded its distribution agreement with GE Healthcare (NYSE:GE) to include the global distribution of its VolparaDensity software. Wellington, New Zealand-based Volpara said that its VolparaDensity software is designed to analyze mammograms using machine learning to provide automated, objective and volumetric breast density assessments and a breast density category that correlates to BI-RADS 5th and 5th editions. “There are still certain signs of breast cancer that are best seen on a mammogram, which is why the Invenia ABUS is used in addition to mammography. ABUS screen...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Distribution Imaging Software / IT Women's Health GE Healthcare Volpara Solutions Source Type: news
More News: Mammography | Ultrasound